Literature DB >> 11856908

Daily hemodialysis: an update.

Andreas Pierratos1.   

Abstract

The interest in daily hemodialysis in the form of short daily hemodialysis and nocturnal hemodialysis has continued to increase over the past few years. A significant number of publications support the evidence for improved outcomes in most of the study areas, including financial benefits. The increased direct cost of the provision of daily hemodialysis seems to be the main obstacle to the wider acceptance of these methods. Convincing data of improved outcomes and evidence of cost efficiency of daily hemodialysis are being generated. These data may increase the interest of the institutional payors as well as of the dialysis industry to create the proper infrastructure for the use of daily hemodialysis. These dialysis regimens promise to have a major impact on the management of end-stage renal disease.

Entities:  

Mesh:

Year:  2002        PMID: 11856908     DOI: 10.1097/00041552-200203000-00006

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  4 in total

1.  Dialysis: Nocturnal hemodialysis--should we still provide this therapy?

Authors:  Peter G Kerr
Journal:  Nat Rev Nephrol       Date:  2011-09-20       Impact factor: 28.314

2.  The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure.

Authors:  Fariba Shaikhi Shoshtari; Sasan Biranvand; Leila Rezaei; Nader Salari; Nasrin Aghaei
Journal:  Int Ophthalmol       Date:  2021-03-19       Impact factor: 2.031

3.  Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.

Authors:  Brian S Decker; Michael B Kays; Mary Chambers; Michael A Kraus; Sharon M Moe; Kevin M Sowinski
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

Review 4.  Safety of new phosphate binders for chronic renal failure.

Authors:  Mahmoud Loghman-Adham
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.